These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35116819)

  • 1. Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection.
    Guan S; Chen Y; Han Q; Deng G; Wang Y; Shi Y; Dai G
    Transl Cancer Res; 2019 Jun; 8(3):811-820. PubMed ID: 35116819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy.
    Zhou W; Yang F; Peng J; Wang F; Lin Y; Jiang W; Yang X; Li L; Lu Z; Wan D; Pan Z; Fan W
    J Cancer; 2019; 10(16):3810-3818. PubMed ID: 31333798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma.
    Xu HX; Li S; Wu CT; Qi ZH; Wang WQ; Jin W; Gao HL; Zhang SR; Xu JZ; Liu C; Long J; Xu J; Ni QX; Yu XJ; Liu L
    Pancreatology; 2018 Sep; 18(6):671-677. PubMed ID: 30153903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis.
    Mattiucci GC; Morganti AG; Cellini F; Buwenge M; Casadei R; Farioli A; Alfieri S; Arcelli A; Bertini F; Calvo FA; Cammelli S; Fuccio L; Giaccherini L; Guido A; Herman JM; Macchia G; Maidment BW; Miller RC; Minni F; Regine WF; Reni M; Partelli S; Falconi M; Valentini V
    Transl Oncol; 2019 Jan; 12(1):1-7. PubMed ID: 30237099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy.
    Shan J; Gu B; Shi L; Wang X; Ye W; Zhou W; Sun X
    Transl Cancer Res; 2021 Jan; 10(1):88-98. PubMed ID: 35116242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Serum Carbohydrate Antigen 19-9 Concentration Is a Predictor of Survival of Patients Who Have Undergone Curative Resection of Stage IV Rectal Cancer.
    Miki H; Akiyoshi T; Ogura A; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Noma H; Saiura A; Fukunaga Y; Ueno M
    Dig Surg; 2018; 35(5):389-396. PubMed ID: 28858867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Early Recurrence Factors of Preoperative Clinicophysiological Findings in Pancreatic Cancer.
    Suzuki S; Shimoda M; Shimazaki J; Maruyama T; Oshiro Y; Nishida K; Sahara Y; Nagakawa Y; Tsuchida A
    Eur Surg Res; 2018; 59(5-6):329-338. PubMed ID: 30453288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
    Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
    Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
    Ferrone CR; Finkelstein DM; Thayer SP; Muzikansky A; Fernandez-delCastillo C; Warshaw AL
    J Clin Oncol; 2006 Jun; 24(18):2897-902. PubMed ID: 16782929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.
    Berger AC; Meszoely IM; Ross EA; Watson JC; Hoffman JP
    Ann Surg Oncol; 2004 Jul; 11(7):644-9. PubMed ID: 15197014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
    Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
    Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative predictors for early recurrence of resectable pancreatic cancer.
    Nishio K; Kimura K; Amano R; Yamazoe S; Ohrira G; Nakata B; Hirakawa K; Ohira M
    World J Surg Oncol; 2017 Jan; 15(1):16. PubMed ID: 28069033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma.
    Ishido K; Kimura N; Wakiya T; Nagase H; Hara Y; Kanda T; Fujita H; Hakamada K
    Ann Surg Oncol; 2022 Feb; 29(2):1281-1293. PubMed ID: 34608555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: the influence of pre- and post- operative adjuvant therapy.
    Suto H; Okano K; Oshima M; Ando Y; Takahashi S; Shibata T; Kamada H; Kobara H; Masaki T; Suzuki Y
    BMC Surg; 2019 Dec; 19(1):186. PubMed ID: 31796066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
    Zhang LP; Ren H; Du YX; Zheng XH; Zhang ZM; Wang CF
    World J Gastrointest Surg; 2021 Mar; 13(3):279-302. PubMed ID: 33796216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma.
    Smith RA; Bosonnet L; Ghaneh P; Raraty M; Sutton R; Campbell F; Neoptolemos JP
    Dig Surg; 2008; 25(3):226-32. PubMed ID: 18577869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of CA19-9 following resection for pancreatic ductal adenocarcinoma is not tantamount to being cured?
    Chen T; Zhang MG; Yu XJ; Liu L
    Asian Pac J Cancer Prev; 2015; 16(2):661-6. PubMed ID: 25684504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative CA19-9 is a prognostic factor in pT3N0 gastric cancer patients undergoing curative resection.
    Maruyama T; Akashi Y; Hakoda H; Sako A; Ueda K; Kato S; Azuma K; Kaneko Y; Ikeguchi A; Nagai S; Oda T
    Langenbecks Arch Surg; 2022 Sep; 407(6):2273-2279. PubMed ID: 35551467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection.
    Chen Q; Zheng Y; Zhao H; Cai J; Wang L; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Wu J
    Ann Transl Med; 2020 Mar; 8(5):192. PubMed ID: 32309339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
    Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
    Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.